| scholarly article | Q13442814 |
| P356 | DOI | 10.1586/ERI.11.178 |
| P8608 | Fatcat ID | release_q4nvhed5yzfn3fsrfg6ojbn4d4 |
| P932 | PMC publication ID | 3318911 |
| P698 | PubMed publication ID | 22397564 |
| P5875 | ResearchGate publication ID | 221684228 |
| P50 | author | Edecio Cunha-Neto | Q38543773 |
| Jorge Elias Kalil Filho | Q56378220 | ||
| Matthias von Herrath | Q64532773 | ||
| P2093 | author name string | Tobias Boettler | |
| P2860 | cites work | The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? | Q24652185 |
| Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection | Q27318086 | ||
| Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans | Q27473420 | ||
| Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal | Q28469094 | ||
| A DNA vaccine encoding multiple HIV CD4 epitopes elicits vigorous polyfunctional, long-lived CD4+ and CD8+ T cell responses | Q28742853 | ||
| Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial | Q28972526 | ||
| Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand | Q29547531 | ||
| T-cell quality in memory and protection: implications for vaccine design | Q30014840 | ||
| HIV disease progression: immune activation, microbes, and a leaky gut. | Q33295161 | ||
| A multicenter, randomized, double-blind, placebo-controlled trial of recombinant human interleukin-10 in HIV-infected subjects | Q33335327 | ||
| Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. | Q33709283 | ||
| DNA immunization to prevent autoimmune diabetes | Q33855482 | ||
| Rational antibody-based HIV-1 vaccine design: current approaches and future directions | Q33937285 | ||
| HIV preferentially infects HIV-specific CD4+ T cells | Q33958893 | ||
| An HIV vaccine--challenges and prospects | Q34013570 | ||
| High levels of viral replication contrast with only transient changes in CD4(+) and CD8(+) cell numbers during the early phase of experimental infection with simian immunodeficiency virus SIVmnd-1 in Mandrillus sphinx | Q34348128 | ||
| Th17 and regulatory T cells: implications for AIDS pathogenesis | Q34395054 | ||
| Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. | Q34569888 | ||
| Plasma levels of soluble CD14 independently predict mortality in HIV infection | Q34764002 | ||
| Glycerol monolaurate prevents mucosal SIV transmission | Q34957016 | ||
| Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection | Q34994754 | ||
| Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine | Q35009558 | ||
| Regulatory T cells control HIV replication in activated T cells through a cAMP-dependent mechanism | Q35029947 | ||
| Natural versus adaptive regulatory T cells | Q35092554 | ||
| Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primary HIV-1 pathogenesis | Q35109877 | ||
| Association of IL-10-promoter genetic variants with the rate of CD4 T-cell loss, IL-10 plasma levels, and breadth of cytotoxic T-cell lymphocyte response during chronic HIV-1 infection | Q35632906 | ||
| The paradox of simian immunodeficiency virus infection in sooty mangabeys: active viral replication without disease progression | Q35650877 | ||
| Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. | Q35845894 | ||
| HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. | Q35848896 | ||
| Preservation of FoxP3+ regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite suppressors correlates with low CD4+ T-cell activation. | Q36845770 | ||
| Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. | Q36891917 | ||
| FoxP3+CD4+ regulatory T cells play an important role in acute HIV-1 infection in humanized Rag2-/-gammaC-/- mice in vivo | Q36915916 | ||
| Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens | Q36954734 | ||
| CD127 and CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV infection | Q37195654 | ||
| Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge | Q37232824 | ||
| HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis | Q37413781 | ||
| Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response | Q37452359 | ||
| Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine? | Q37519312 | ||
| Inhibition of acute in vivo human immunodeficiency virus infection by human interleukin 10 treatment of SCID mice implanted with human fetal thymus and liver. | Q37687694 | ||
| Depletion of regulatory T cells in HIV infection is associated with immune activation | Q38881101 | ||
| Persistent immune activation in HIV-1 infection is associated with progression to AIDS. | Q39060564 | ||
| Suppressed cellular alloimmune responses in HIV-exposed seronegative female sex workers. | Q39104486 | ||
| Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner | Q42107193 | ||
| Decreased immune activation in resistance to HIV-1 infection is associated with an elevated frequency of CD4(+)CD25(+)FOXP3(+) regulatory T cells | Q43468180 | ||
| HIV‐exposed seronegative commercial sex workers show a quiescent phenotype in the CD4+ T cell compartment and reduced expression of HIV‐dependent host factors | Q43753402 | ||
| Reduced mortality and CD4 cell loss among carriers of the interleukin-10 -1082G allele in a Zimbabwean cohort of HIV-1-infected adults. | Q44167410 | ||
| Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells | Q44986020 | ||
| Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients | Q45609885 | ||
| Cytokine pattern in relation to disease progression in human immunodeficiency virus-infected children. | Q45765515 | ||
| The fate of human Treg cells. | Q45886217 | ||
| Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia | Q48023288 | ||
| Memory CCR6+CD4+ T cells are preferential targets for productive HIV type 1 infection regardless of their expression of integrin β7. | Q50638760 | ||
| Passive immunization with human neutralizing monoclonal antibodies against HIV-1 in macaque models: experimental approaches. | Q51791621 | ||
| Pre-seroconversion immune status predicts the rate of CD4 T cell decline following HIV infection. | Q51998041 | ||
| CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. | Q52010705 | ||
| Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load | Q58034113 | ||
| HIV vaccine failure prompts Merck to halt trial | Q59098676 | ||
| IL-10-secreting T cells from HIV-infected pregnant women downregulate HIV-1 replication: effect enhanced by antiretroviral treatment | Q61762161 | ||
| Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse | Q73153290 | ||
| Low-level CD4+ T cell activation is associated with low susceptibility to HIV-1 infection | Q81375635 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 299-305 | |
| P577 | publication date | 2012-03-01 | |
| P1433 | published in | Expert Review of Anti-infective Therapy | Q15734432 |
| P1476 | title | Can an immune-regulatory vaccine prevent HIV infection? | |
| P478 | volume | 10 |
Search more.